Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy in Vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified With Cancer-Specific Monoclonal Antibody
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-2392
Full Text
Open PDFAbstract
Available in full text
Date
March 10, 2009
Authors
Publisher
American Association for Cancer Research (AACR)